# Michael L. Nordlund, MD, PhD – FDA Inspection, Oct 18, 2017

Source: https://www.keypedia.com/records/fda_inspections/michael-l-nordlund-md-phd/e8e2ef7d-403d-4513-9881-8fdff91399e6
Source feed: FDA_Inspections

> FDA inspection 1028985 of Michael L. Nordlund, MD, PhD, October 18, 2017. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1028985
- Company Name: Michael L. Nordlund, MD, PhD
- Inspection Date: 2017-10-18
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Officers

- [Kathryn Suttling](https://www.keypedia.com/people/kathryn-suttling/40a22409-8aba-4e9f-826b-0af51c1a7c0b)
- [Company Rep](https://www.keypedia.com/people/marcia-a-worley/bbcc8e30-05b1-4ad4-85da-17209ace9246)

Company: https://www.keypedia.com/companies/michael-l-nordlund-md-phd/58baf9ab-c1e4-4a47-b08b-f8b526388352

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c